Statistics for Generation Bio (id:8177 GBIO)

Valuation metrics

Market cap

95.51M

Enterprise value

11.87M

Trailing P/E (ttm)

-0.70

Forward P/E

-1.29

PEG ratio

-1.29

Price/Sales (ttm)

5.14

Price/Book (mrq)

0.91

Enterprise Value/Revenue

0.64

Enterprise Value/EBITDA

-0.13

Overview

Shares outstanding

66.79M

Float

48.82M

Shares short

1.66M

% Held by insiders

0.15%

% Held by institutions

0.84%

Average volume (10 days)

223.66K

Average volume (90 days)

Price summary

52-Week low

1.10

52-Week high

4.65

52-Week change

15.33%

Beta

2.82

50-Day moving average

2.35

200-Day moving average

2.76

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-221.27%

Operational effectiveness

Return on assets

-19.29%

Return on equity

-86.50%

Income statement

Revenue (ttm)

0.28

Revenue per share (ttm)

0.28

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-92,192,000.00

Net income to common (ttm)

-145,472,000.00

Diluted EPS (ttm)

-2.19

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

184.77M

Total cash per share (mrq)

2.77

Total debt (mrq)

93.78M

Total Debt/Equity (mrq)

89.79

Current ratio (mrq)

634.00%

Book value per share (mrq)

1.56

Cash flow

Cash flow statement

-97,757,000.00

Levered free cash flow (LFCF)

-49,251,000.00